查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1602125

特種藥品分銷市場：按適應症、經銷商類型、分銷類型、最終用戶分類 - 2025-2030 年全球預測

Specialty Drug Distribution Market by Disease Indication (AIDS, Hemophilia, Multiple Sclerosis), Distributor Type (Full line Wholesalers, Specialty Distributors), Distribution Type, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年專科藥品分銷市場規模為47.6億美元，預計2024年將達到54.7億美元，複合年成長率為14.44%，預計到2030年將達到122.5億美元。

特殊藥品流通市場主要涉及需要綜合處理的特殊藥品的供應和管理，例如高成本、需要特定儲存和管理的藥品。這些藥物包括治療癌症、愛滋病毒和多發性硬化症等慢性疾病，通常需要單獨的通路。對個人化醫療的需求不斷成長，以及對能夠管理複雜物流並防止潛在瓶頸的創新輸送系統的需求，強調了對特種藥物分銷的需求。透過應用，該市場透過高效、安全地提供所需藥物來為藥房、醫院和診所提供支持，同時患者也可以從確保最佳健康結果的專門治療方法中受益。這種分配模式主要服務於醫療保健部門，並影響公共和私人組織。

主要市場統計
基準年[2023] 47.6億美元
預測年份 [2024] 54.7億美元
預測年份 [2030] 122.5億美元
複合年成長率（%） 14.44%

區塊鏈和物聯網等創新技術正在使供應鏈更加安全和透明，生技藥品和基因治療的快速成長被認為是市場擴張的關鍵驅動力。強調以患者為中心的照護模式將擴大宅配服務和基於價值的安排的機會，從而提供新的成長機會。然而，監管複雜性、特種藥物的高成本和報銷問題等挑戰可能會構成重大障礙並影響市場動態。農村地區有限的基礎設施可能進一步阻礙有效的分配。

為了克服這些挑戰，該行業必須投資數位健康平台和資料分析，以最佳化供應鏈並提高病人參與。低溫運輸物流和自動化的創新可以顯著降低管理成本並提高配送效率。市場的本質是技術快速進步和嚴格的法規環境，因此需要積極採用新技術並促進相關人員之間的合作。促進配方和輸送機制的創新，再加上與高科技公司的策略夥伴關係關係，將增強我們有效克服挑戰的能力，並確保在特種藥品分銷市場上的永續性和競爭優勢。

市場動態：揭示快速發展的專業藥品分銷市場的關鍵市場洞察

供需的動態交互作用正在改變專科藥品分銷市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 增加特種藥物開發平臺和交易
    • 強調最佳化藥品成本、供應和儲存，以提供以病人為中心的護理
  • 市場限制因素
    • 管理各種分銷管道的複雜性
  • 市場機會
    • 整合特種藥物分銷的新技術與進步
    • 在世界各地擴張專業藥房
  • 市場挑戰
    • 與專科藥物相關的法規結構的變化

波特五力：駕馭特種藥品經銷市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解專業藥品分銷市場的外部影響

外部宏觀環境因素在塑造專業藥品分銷市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解專科藥品分銷市場的競爭狀況

對專業藥品分銷市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 專業藥品分銷市場供應商定位矩陣績效評估

FPNV 定位矩陣是評估專業藥品分銷市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 增加特種藥物開發平臺和交易
      • 專注於最佳化藥品成本、供應和儲存，提供以患者為中心的護理
    • 抑制因素
      • 管理各種分銷管道的複雜性
    • 機會
      • 整合及推進特種藥物分銷新技術
      • 專業藥局正在世界各地擴張
    • 任務
      • 與特殊藥物處理相關的法規結構的變化
  • 市場區隔分析
    • 疾病適應症：治療腫瘤疾病的專用藥物需求增加
    • 經銷商類型：特種藥品的全線批發商日益增多
    • 分銷形式：專科藥局滲透率高
    • 最終用戶：家庭環境中專業藥品分配的新可能性
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 專科藥品流通市場：依適應症分類

  • 愛滋病
  • 血友病
  • 多發性硬化症
  • 腫瘤學
  • 類風濕性關節炎

第7章 專業藥品分銷市場：經銷商類型

  • 全線批發商
  • 專業經銷商

第8章 專業藥品分銷市場：依分銷類型

  • 醫院/診所藥房
  • 獨立藥房
  • 大型連鎖藥房
  • 通訊藥房
  • 網路商店
  • 專業藥房

第9章 專業藥品分銷市場：依最終用戶分類

  • 門診手術中心
  • 醫療保健付款人
  • 主頁設定
  • 醫院/診所

第10章美洲專業藥品經銷市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區特種藥品分銷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的特用藥品分銷市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • FFF Enterprises 宣布與 Verrica Pharmaceuticals 合作，成為 YCANTH 的獨家經銷商，YCANTH 是 FDA核准的第一種傳染性軟疣治療藥物
    • Orsini Specialty Pharmacy 已被選為 VEOPOZ (poselimab-BBFG) 的獨家專業藥房合作夥伴，VEOPOZ (poselimab-BBFG) 是第一個也是唯一一個治療 CHAPLE 疾病的藥物。
    • Medis 與 ESTEVE 在 10 個中東歐國家簽署經銷協議
    • 珠峰醫藥宣布與上海醫藥子公司達成策略聯盟，加速XERAVA在中國當地的商業化
    • Elevance Health 宣布完成 Bioplus 收購
    • CVS Health 收購 Oak Street Health
    • Shields Health Solutions 與 MyMichigan Health 合作，加強為患者和家庭提供的專業藥房服務
    • Seals Health Solutions 擴大全國夥伴關係關係以改善專業藥房服務
    • Prime Therapeutics 完成以 13.5 億美元收購 Magellan Rx，結合藥學和藥品管理專業知識
    • 加拿大麥克森推出新的數位生態系統，以簡化和增強專業患者的治療效果
    • 宏利和 Shoppers Drug Mart 聯手幫助管理嚴重的醫療狀況
    • Marken 同意收購 Cedra Express 的醫療宅配業務，擴大在紐西蘭的直接業務
    • 康德樂繼續拓展家庭解決方案業務
    • Harozyme 將以約 9.6 億美元收購 Antares Pharma

公司名單

  • Shanghai Pharmaceuticals Group Co., Ltd.
  • CVS Specialty, Inc. by CVS Health Corporation
  • AmerisourceBergen Corporation
  • China National Pharmaceutical Group Corporation
  • Teva Pharmaceutical Industries Ltd.
  • McKesson Corporation
  • Suzuken Co., Ltd.
  • Eversana
  • PHOENIX Pharmahandel GmbH & Co KG
  • Accredo Health Group, Inc.
  • Lifeline Pharmaceuticals, LLC
  • Aark Pharmaceuticals
  • Optum, Inc.
  • Feron Healthcare Pvt Ltd.
  • Morris & Dickson Co., LLC
  • Medipal Holdings Corporation
  • Kroger Specialty Pharmacy
  • Walmart Inc.
  • Elevance Health, Inc.
  • FFF Enterprises Inc.
  • Cardinal Health, Inc.
  • Shields Health Solutions Holdings, LLC
  • Medis Intago, doo
  • Marken by United Parcel Service, Inc.
  • Centene Corporation
  • Sun Pharmaceutical Industries Limited
  • BioCare, Inc.
Product Code: MRR-43192CEFCC35

The Specialty Drug Distribution Market was valued at USD 4.76 billion in 2023, expected to reach USD 5.47 billion in 2024, and is projected to grow at a CAGR of 14.44%, to USD 12.25 billion by 2030.

The specialty drug distribution market primarily involves the supply and management of specialized pharmaceuticals that require comprehensive handling, including drugs with high costs and specific storage or administration needs. These include treatments for chronic diseases such as cancer, HIV, and multiple sclerosis, often necessitating a tailored distribution channel. The necessity of specialty drug distribution is underscored by the growing demand for personalized medicine and the need for innovative delivery systems that can manage complex logistics and safeguard against potential disruptions. Application-wise, the market supports pharmacies, hospitals, and clinics by providing necessary drugs efficiently and safely, while patients benefit from specialized therapeutic regimens ensuring optimal health outcomes. This distribution model predominantly serves the healthcare sector, influencing both public and private entities.

KEY MARKET STATISTICS
Base Year [2023] USD 4.76 billion
Estimated Year [2024] USD 5.47 billion
Forecast Year [2030] USD 12.25 billion
CAGR (%) 14.44%

Recent market insights point to the burgeoning growth of biologics and gene therapies as primary factors driving market expansion, with innovative technologies like blockchain and IoT enhancing supply chain security and transparency. The emphasis on patient-centric care models expands opportunities for home delivery services and value-based arrangements, providing new avenues for growth. However, challenges such as regulatory complexities, high costs of specialty drugs, and reimbursement issues pose significant obstacles, potentially affecting market dynamics. Limited infrastructure in rural areas may further hinder efficient distribution.

To surmount these challenges, the industry should invest in digital health platforms and data analytics to optimize supply chains and enhance patient engagement. Innovations in cold chain logistics and automation can significantly reduce overhead costs and improve distribution efficacy. The market's nature, characterized by rapid technological advancement and stringent regulatory environments, necessitates a proactive approach in adopting emerging technologies and fostering collaborations between stakeholders. Encouraging innovation in drug formulation and delivery mechanisms, combined with strategic partnerships with tech firms, will bolster the capacity to navigate challenges effectively, ensuring sustainability and competitive advantage in the specialty drug distribution market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Specialty Drug Distribution Market

The Specialty Drug Distribution Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing specialty drug development pipeline and trade
    • Emphasis on drug cost, supply, and storage optimization to offer patient-centric care
  • Market Restraints
    • Complexity in managing different distribution channels
  • Market Opportunities
    • New technology integration and advancements in specialty drug distribution
    • Rising expansion of specialty pharmacies worldwide
  • Market Challenges
    • Changing regulatory frameworks associated with specialty drug handling

Porter's Five Forces: A Strategic Tool for Navigating the Specialty Drug Distribution Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Specialty Drug Distribution Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Specialty Drug Distribution Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Specialty Drug Distribution Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Specialty Drug Distribution Market

A detailed market share analysis in the Specialty Drug Distribution Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Specialty Drug Distribution Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Specialty Drug Distribution Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Specialty Drug Distribution Market, highlighting leading vendors and their innovative profiles. These include Shanghai Pharmaceuticals Group Co., Ltd., CVS Specialty, Inc. by CVS Health Corporation, AmerisourceBergen Corporation, China National Pharmaceutical Group Corporation, Teva Pharmaceutical Industries Ltd., McKesson Corporation, Suzuken Co., Ltd., Eversana, PHOENIX Pharmahandel GmbH & Co KG, Accredo Health Group, Inc., Lifeline Pharmaceuticals, LLC, Aark Pharmaceuticals, Optum, Inc., Feron Healthcare Pvt Ltd., Morris & Dickson Co., LLC, Medipal Holdings Corporation, Kroger Specialty Pharmacy, Walmart Inc., Elevance Health, Inc., FFF Enterprises Inc., Cardinal Health, Inc., Shields Health Solutions Holdings, LLC, Medis Intago, d.o.o., Marken by United Parcel Service, Inc., Centene Corporation, Sun Pharmaceutical Industries Limited, and BioCare, Inc..

Market Segmentation & Coverage

This research report categorizes the Specialty Drug Distribution Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Disease Indication, market is studied across AIDS, Hemophilia, Multiple Sclerosis, Oncology, and Rheumatoid Arthritis.
  • Based on Distributor Type, market is studied across Full line Wholesalers and Specialty Distributors.
  • Based on Distribution Type, market is studied across Hospitals & Clinic Pharmacies, Independent Pharmacies, Large Chain Pharmacies, Mail-Order Pharmacies, Online Stores, and Specialty Pharmacies.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Healthcare Payers, Home Settings, and Hospital & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing specialty drug development pipeline and trade
      • 5.1.1.2. Emphasis on drug cost, supply, and storage optimization to offer patient-centric care
    • 5.1.2. Restraints
      • 5.1.2.1. Complexity in managing different distribution channels
    • 5.1.3. Opportunities
      • 5.1.3.1. New technology integration and advancements in specialty drug distribution
      • 5.1.3.2. Rising expansion of specialty pharmacies worldwide
    • 5.1.4. Challenges
      • 5.1.4.1. Changing regulatory frameworks associated with specialty drug handling
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Disease Indication: Escalated need of specialty drugs to treat oncology conditions
    • 5.2.2. Distributor Type: Rising presence of full line wholesalers of speciality drugs
    • 5.2.3. Distribution Type: Significant penetration in specialty pharmacies
    • 5.2.4. End-User: Emerging potential for specialty drug distribution in home settings
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Specialty Drug Distribution Market, by Disease Indication

  • 6.1. Introduction
  • 6.2. AIDS
  • 6.3. Hemophilia
  • 6.4. Multiple Sclerosis
  • 6.5. Oncology
  • 6.6. Rheumatoid Arthritis

7. Specialty Drug Distribution Market, by Distributor Type

  • 7.1. Introduction
  • 7.2. Full line Wholesalers
  • 7.3. Specialty Distributors

8. Specialty Drug Distribution Market, by Distribution Type

  • 8.1. Introduction
  • 8.2. Hospitals & Clinic Pharmacies
  • 8.3. Independent Pharmacies
  • 8.4. Large Chain Pharmacies
  • 8.5. Mail-Order Pharmacies
  • 8.6. Online Stores
  • 8.7. Specialty Pharmacies

9. Specialty Drug Distribution Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Healthcare Payers
  • 9.4. Home Settings
  • 9.5. Hospital & Clinics

10. Americas Specialty Drug Distribution Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Specialty Drug Distribution Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Specialty Drug Distribution Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. FFF Enterprises Announces its Partnership with Verrica Pharmaceuticals to be the Exclusive Distributor of YCANTH, the First FDA Approved Treatment for Molluscum Contagiosum
    • 13.3.2. Orsini Specialty Pharmacy Selected to be the Exclusive Specialty Pharmacy Partner for VEOPOZ (pozelimab-bbfg), the First and Only Treatment for CHAPLE Disease
    • 13.3.3. Medis and ESTEVE Signed a Distribution Agreement for 10 CEE Countries
    • 13.3.4. Everest Medicines Announces Strategic Partnership with Shanghai Pharma Subsidiary to Accelerate the Commercialization of XERAVA in Mainland China
    • 13.3.5. Elevance Health Announces Closing of BioPlus Acquisition
    • 13.3.6. CVS Health to acquire Oak Street Health
    • 13.3.7. Shields Health Solutions and MyMichigan Health Partner to Enhance Specialty Pharmacy Services for Patients and Families
    • 13.3.8. Shields Health Solutions Expands Nationwide Partnerships to Enhance Specialty Pharmacy Services
    • 13.3.9. Prime Therapeutics Closes USD 1.35 Billion Magellan Rx Acquisition, Uniting Pharmacy and Medical Drug Management Expertise
    • 13.3.10. McKesson Canada Launches New Digital Ecosystem to Simplify and Enhance Specialty Patient Outcomes
    • 13.3.11. Manulife and Shoppers Drug Mart Collaborate to Help Manage Serious Medical Conditions
    • 13.3.12. Marken Reaches Agreement to Acquire the Medical Courier Business of Cedra Express, Expands Direct Presence in New Zealand
    • 13.3.13. Cardinal Health Continues to Expand at-Home Solutions Business
    • 13.3.14. Halozyme to Acquire Antares Pharma for Around USD 960 Million

Companies Mentioned

  • 1. Shanghai Pharmaceuticals Group Co., Ltd.
  • 2. CVS Specialty, Inc. by CVS Health Corporation
  • 3. AmerisourceBergen Corporation
  • 4. China National Pharmaceutical Group Corporation
  • 5. Teva Pharmaceutical Industries Ltd.
  • 6. McKesson Corporation
  • 7. Suzuken Co., Ltd.
  • 8. Eversana
  • 9. PHOENIX Pharmahandel GmbH & Co KG
  • 10. Accredo Health Group, Inc.
  • 11. Lifeline Pharmaceuticals, LLC
  • 12. Aark Pharmaceuticals
  • 13. Optum, Inc.
  • 14. Feron Healthcare Pvt Ltd.
  • 15. Morris & Dickson Co., LLC
  • 16. Medipal Holdings Corporation
  • 17. Kroger Specialty Pharmacy
  • 18. Walmart Inc.
  • 19. Elevance Health, Inc.
  • 20. FFF Enterprises Inc.
  • 21. Cardinal Health, Inc.
  • 22. Shields Health Solutions Holdings, LLC
  • 23. Medis Intago, d.o.o.
  • 24. Marken by United Parcel Service, Inc.
  • 25. Centene Corporation
  • 26. Sun Pharmaceutical Industries Limited
  • 27. BioCare, Inc.

LIST OF FIGURES

  • FIGURE 1. SPECIALTY DRUG DISTRIBUTION MARKET RESEARCH PROCESS
  • FIGURE 2. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. SPECIALTY DRUG DISTRIBUTION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. SPECIALTY DRUG DISTRIBUTION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SPECIALTY DRUG DISTRIBUTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SPECIALTY DRUG DISTRIBUTION MARKET DYNAMICS
  • TABLE 7. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY AIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HEMOPHILIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY FULL LINE WHOLESALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITALS & CLINIC PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY LARGE CHAIN PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MAIL-ORDER PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HEALTHCARE PAYERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. SPECIALTY DRUG DISTRIBUTION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 197. SPECIALTY DRUG DISTRIBUTION MARKET, FPNV POSITIONING MATRIX, 2023